Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

This study has been terminated.

(Study terminated as principal investigator [PI] left the university.)

Sponsor:

Information provided by:

Masonic Cancer Center, University of Minnesota

ClinicalTrials.gov Identifier:

NCT00005984

First received: July 5, 2000

Last updated: May 25, 2011

Last verified: May 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2005
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)